2022. “To Study The Association Of Leptin As A Predictive Marker In Obese And Non-Obese Women With Polycystic Ovary Syndrome Patients.”. Journal of Pharmaceutical Negative Results. (Dec. 2022), 3930–3940. DOI:https://doi.org/10.47750/pnr.2022.13.S08.495.